Jan 9, 2026 06:01PM
Jan 5, 2026 08:30AM
Aug 20, 2025 08:25AM
May 25, 2025 03:00PM
May 2, 2025 10:48AM
Jan 29, 2025 09:41AM
Jan 12, 2025 05:00PM Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference
Jan 6, 2025 08:30AM
Sep 20, 2024 06:16AM
Sep 19, 2024 08:16PM
Sep 18, 2024 04:04PM
Sep 18, 2024 04:04PM
Aug 21, 2024 06:21AM
Jan 8, 2024 05:23AM Ascendis Pharma (ASND) Introduces Vision 2030
Jan 7, 2024 05:45PM
Dec 28, 2023 04:15PM
Nov 16, 2023 09:00AM
Jan 9, 2023 04:59AM
Jan 8, 2023 05:00PM
Jan 3, 2023 08:00AM
Mar 16, 2022 06:47AM JPMorgan's Top 99 Names to Buy/Own On The Market Pullback
Jan 10, 2022 08:00AM
Jan 4, 2022 08:00AM
Sep 29, 2021 04:01PM
Sep 29, 2021 04:01PM
Sep 2, 2021 05:23AM
Sep 1, 2021 07:43PM
Aug 31, 2021 04:01PM Ascendis Pharma (ASND) to Offer $400M in Common Stock
Aug 31, 2021 04:01PM
Mar 30, 2021 07:05AM
Jan 10, 2021 07:04PM
Jan 4, 2021 07:05AM
Jul 8, 2020 06:01AM
Jul 7, 2020 10:11PM
Jul 6, 2020 01:00PM Ascendis Pharma (ASND) Announces Proposed $500M ADS Offering
Jul 6, 2020 12:58PM
Jan 12, 2020 07:45PM
Jan 9, 2020 04:00PM
Jun 26, 2019 12:50PM
Mar 6, 2019 05:57AM
Mar 5, 2019 08:07PM
Mar 4, 2019 04:01PM Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
Mar 4, 2019 04:00PM
Mar 4, 2019 09:09AM
Jan 7, 2019 09:00AM
Dec 21, 2018 04:01PM
Nov 8, 2018 04:48PM
May 14, 2018 08:04AM
Mar 21, 2018 06:25AM Ascendis Pharma (ASND) PT Raised to $75 at JPMorgan; 'Pipeline Updates Increase Our Confidence'
Feb 21, 2018 11:45PM

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All